- Home
- SURG vs CALC Comparison
SURG vs CALC Comparison
Compare SURG & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- CALC
- Stock Information
- Founded
- SURG 2006
- CALC 2011
- Country
- SURG United States
- CALC United States
- Employees
- SURG N/A
- CALC N/A
- Industry
- SURG Advertising
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- SURG Consumer Discretionary
- CALC Health Care
- Exchange
- SURG Nasdaq
- CALC Nasdaq
- Market Cap
- SURG 58.6M
- CALC 48.1M
- IPO Year
- SURG N/A
- CALC N/A
- Fundamental
- Price
- SURG $2.71
- CALC $3.23
- Analyst Decision
- SURG Strong Buy
- CALC Strong Buy
- Analyst Count
- SURG 1
- CALC 2
- Target Price
- SURG $9.50
- CALC $14.50
- AVG Volume (30 Days)
- SURG 93.8K
- CALC 54.4K
- Earning Date
- SURG 11-11-2025
- CALC 11-12-2025
- Dividend Yield
- SURG N/A
- CALC N/A
- EPS Growth
- SURG N/A
- CALC N/A
- EPS
- SURG N/A
- CALC N/A
- Revenue
- SURG $36,461,935.00
- CALC N/A
- Revenue This Year
- SURG $20.20
- CALC N/A
- Revenue Next Year
- SURG $121.54
- CALC N/A
- P/E Ratio
- SURG N/A
- CALC N/A
- Revenue Growth
- SURG N/A
- CALC N/A
- 52 Week Low
- SURG $1.05
- CALC $1.42
- 52 Week High
- SURG $3.47
- CALC $5.65
- Technical
- Relative Strength Index (RSI)
- SURG 47.32
- CALC 54.92
- Support Level
- SURG $2.51
- CALC $2.97
- Resistance Level
- SURG $2.90
- CALC $3.65
- Average True Range (ATR)
- SURG 0.15
- CALC 0.21
- MACD
- SURG -0.02
- CALC 0.01
- Stochastic Oscillator
- SURG 41.67
- CALC 45.59
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.